Having trouble accessing articles? Reset your cache.

Therosteon B.V., TiGenix autoimmune, musculoskeletal news

TiGenix spun out its ChondroBoost screening technology into newco Arcarios B.V. (Rotterdam, Netherlands), which was merged with drug discovery company Therosteon. The newco will focus on developing products to

Read the full 293 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE